Differentiated thyroid carcinoma (papillary and follicular) has a favorable prognosis with an
85% 10-year survival. The patients that recur often require surgery and further radioactive …

Most positron emission tomography (PET) imaging studies in head and neck cancer are
performed using the radiotracer 18-fluorodeoxyglucose (18FDG). PET with FDG has …

Purpose: The purpose of the study was to assess prospectively the impact of recombinant
human TSH (rhTSH) administration on positron emission tomography (PET)/computed …

This article provides an update on functional imaging approaches for diagnostic localization
of endocrine tumors, with emphasis on positron emission tomography (PET).[18F] …

TSH stimulates thyrocyte metabolism, glucose transport, and glycolysis. 2-Deoxy-2-[18F]
fluoro-d-glucose (FDG) is a glucose analog used in positron emission tomography (PET) to …

This article provides an update on the use of 2-[18F]-fluoro-2-deoxyglucose PET in the
follow-up of patients treated for differentiated thyroid carcinoma (DTC). Although DTC …

Aims This study aimed (a) to determine the clinical and histopathologic factors that are
related to FDG avidity in the recurrence/metastases of patients with differentiated thyroid …

The influence of serum TSH levels on fluorine-18 fluorodeoxyglucose (FDG) uptake by
recurrences or metastases of differentiated thyroid carcinomas has not yet been clarified …

Depending on the iodine supply of an area, the incidence of thyroid cancer ranges between
4 and 12/100,000 per year. To detect thyroid cancer in an early stage, the assessment of …

Fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) has evolved from a
research imaging modality assessing brain function in physiologic and pathologic states to a …